DNA Recent News
Market, Policy Trends Are Shifting In Illumina's Favor, Morgan Stanley Says In Upgrade
Exclusive: Dicerna CEO Talks Goals For 2017, Competitors And Prospects Under Trump
Exclusive: Dicerna CEO Discusses Financials And Institutional Investors
Exclusive: Dicerna CEO Talks Products, Partnerships And Stock Performance
Exclusive: Dicerna CEO Explains RNA Interference And How It's Used To Treat Rare Genetic Diseases
Sony and Illumina Set to Change the Way Doctors Identify and Treat Cancer (ILMN, SNE)
Global Market for DNA Sequencing Worth $1.7 Billion by 2013